PHARMEXA Inc.
6Patents
1Active
6Granted
28Portfolio score
Filing activity: May 4, 1993 → May 29, 2008
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7462354B2 | Method and system for optimizing minigenes and peptides encoded thereby | Emerging Cross-Sectional Technologies | 27 | Expired |
| US8969542B2 | HPV polyepitope constructs and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US7202351B1 | Alteration of immune response using pan DR-binding peptides | Emerging Cross-Sectional Technologies | 12 | Expired |
| US7572882B2 | Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions | Chemistry; Metallurgy | 4 | Expired |
| US7611713B2 | Inducing cellular immune responses to hepatitis B virus using peptide compositions | Chemistry; Metallurgy | 1 | Expired |
| US7364741B1 | Peptides of human Papilloma virus for use in human T cell response inducing compositions | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.